Explore the FDA's role in generic drug approval via the ANDA pathway. Learn about bioequivalence, Hatch-Waxman laws, and how quality is ensured.
View MoreExplore prescriber override laws, DAW codes, and when physicians can mandate brand-name dispensing. Learn about state-specific requirements, clinical justifications, and cost impacts.
View MoreLearn how the FDA uses bioequivalence standards to ensure generic drugs are as effective and safe as brand-name medications, covering Cmax, AUC, and the 80-125% rule.
View More